Global Biotechnological Drugs Market Research Report 2023(Status and Outlook)
Report Overview
Bosson Research’s latest report provides a deep insight into the global Biotechnological Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biotechnological Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biotechnological Drugs market in any manner.
Global Biotechnological Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy’s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Market Segmentation (by Type)
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Market Segmentation (by Application)
Tumor
Autoimmune Disease
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biotechnological Drugs Market
Overview of the regional outlook of the Biotechnological Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biotechnological Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Bosson Research’s latest report provides a deep insight into the global Biotechnological Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biotechnological Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biotechnological Drugs market in any manner.
Global Biotechnological Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy’s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals
Market Segmentation (by Type)
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Market Segmentation (by Application)
Tumor
Autoimmune Disease
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biotechnological Drugs Market
Overview of the regional outlook of the Biotechnological Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biotechnological Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biotechnological Drugs
1.2 Key Market Segments
1.2.1 Biotechnological Drugs Segment by Type
1.2.2 Biotechnological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOTECHNOLOGICAL DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biotechnological Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Biotechnological Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOTECHNOLOGICAL DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Biotechnological Drugs Sales by Manufacturers (2018-2023)
3.2 Global Biotechnological Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biotechnological Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Biotechnological Drugs Sales Sites, Area Served, Product Type
3.6 Biotechnological Drugs Market Competitive Situation and Trends
3.6.1 Biotechnological Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biotechnological Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOTECHNOLOGICAL DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Biotechnological Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOTECHNOLOGICAL DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biotechnological Drugs Sales Market Share by Type (2018-2023)
6.3 Global Biotechnological Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Biotechnological Drugs Price by Type (2018-2023)
7 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biotechnological Drugs Market Sales by Application (2018-2023)
7.3 Global Biotechnological Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Biotechnological Drugs Sales Growth Rate by Application (2018-2023)
8 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Biotechnological Drugs Sales by Region
8.1.1 Global Biotechnological Drugs Sales by Region
8.1.2 Global Biotechnological Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Biotechnological Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biotechnological Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biotechnological Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biotechnological Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biotechnological Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 3SBIO
9.1.1 3SBIO Biotechnological Drugs Basic Information
9.1.2 3SBIO Biotechnological Drugs Product Overview
9.1.3 3SBIO Biotechnological Drugs Product Market Performance
9.1.4 3SBIO Business Overview
9.1.5 3SBIO Biotechnological Drugs SWOT Analysis
9.1.6 3SBIO Recent Developments
9.2 Anhui Anke Biotechnology
9.2.1 Anhui Anke Biotechnology Biotechnological Drugs Basic Information
9.2.2 Anhui Anke Biotechnology Biotechnological Drugs Product Overview
9.2.3 Anhui Anke Biotechnology Biotechnological Drugs Product Market Performance
9.2.4 Anhui Anke Biotechnology Business Overview
9.2.5 Anhui Anke Biotechnology Biotechnological Drugs SWOT Analysis
9.2.6 Anhui Anke Biotechnology Recent Developments
9.3 Beijing SL Pharmaceutical
9.3.1 Beijing SL Pharmaceutical Biotechnological Drugs Basic Information
9.3.2 Beijing SL Pharmaceutical Biotechnological Drugs Product Overview
9.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Product Market Performance
9.3.4 Beijing SL Pharmaceutical Business Overview
9.3.5 Beijing SL Pharmaceutical Biotechnological Drugs SWOT Analysis
9.3.6 Beijing SL Pharmaceutical Recent Developments
9.4 Biotech Pharmaceutical
9.4.1 Biotech Pharmaceutical Biotechnological Drugs Basic Information
9.4.2 Biotech Pharmaceutical Biotechnological Drugs Product Overview
9.4.3 Biotech Pharmaceutical Biotechnological Drugs Product Market Performance
9.4.4 Biotech Pharmaceutical Business Overview
9.4.5 Biotech Pharmaceutical Biotechnological Drugs SWOT Analysis
9.4.6 Biotech Pharmaceutical Recent Developments
9.5 Cadila Healthcare
9.5.1 Cadila Healthcare Biotechnological Drugs Basic Information
9.5.2 Cadila Healthcare Biotechnological Drugs Product Overview
9.5.3 Cadila Healthcare Biotechnological Drugs Product Market Performance
9.5.4 Cadila Healthcare Business Overview
9.5.5 Cadila Healthcare Biotechnological Drugs SWOT Analysis
9.5.6 Cadila Healthcare Recent Developments
9.6 Celgen Biopharma
9.6.1 Celgen Biopharma Biotechnological Drugs Basic Information
9.6.2 Celgen Biopharma Biotechnological Drugs Product Overview
9.6.3 Celgen Biopharma Biotechnological Drugs Product Market Performance
9.6.4 Celgen Biopharma Business Overview
9.6.5 Celgen Biopharma Recent Developments
9.7 Celltrion
9.7.1 Celltrion Biotechnological Drugs Basic Information
9.7.2 Celltrion Biotechnological Drugs Product Overview
9.7.3 Celltrion Biotechnological Drugs Product Market Performance
9.7.4 Celltrion Business Overview
9.7.5 Celltrion Recent Developments
9.8 Dr Reddy’s
9.8.1 Dr Reddy’s Biotechnological Drugs Basic Information
9.8.2 Dr Reddy’s Biotechnological Drugs Product Overview
9.8.3 Dr Reddy’s Biotechnological Drugs Product Market Performance
9.8.4 Dr Reddy’s Business Overview
9.8.5 Dr Reddy’s Recent Developments
9.9 GeneScience Pharmaceuticals
9.9.1 GeneScience Pharmaceuticals Biotechnological Drugs Basic Information
9.9.2 GeneScience Pharmaceuticals Biotechnological Drugs Product Overview
9.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Product Market Performance
9.9.4 GeneScience Pharmaceuticals Business Overview
9.9.5 GeneScience Pharmaceuticals Recent Developments
9.10 Hisun Pharma
9.10.1 Hisun Pharma Biotechnological Drugs Basic Information
9.10.2 Hisun Pharma Biotechnological Drugs Product Overview
9.10.3 Hisun Pharma Biotechnological Drugs Product Market Performance
9.10.4 Hisun Pharma Business Overview
9.10.5 Hisun Pharma Recent Developments
9.11 Jiangsu Sihuan Bioengineering
9.11.1 Jiangsu Sihuan Bioengineering Biotechnological Drugs Basic Information
9.11.2 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Overview
9.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Market Performance
9.11.4 Jiangsu Sihuan Bioengineering Business Overview
9.11.5 Jiangsu Sihuan Bioengineering Recent Developments
9.12 Novartis (Sandoz)
9.12.1 Novartis (Sandoz) Biotechnological Drugs Basic Information
9.12.2 Novartis (Sandoz) Biotechnological Drugs Product Overview
9.12.3 Novartis (Sandoz) Biotechnological Drugs Product Market Performance
9.12.4 Novartis (Sandoz) Business Overview
9.12.5 Novartis (Sandoz) Recent Developments
9.13 Pfizer (Hospira)
9.13.1 Pfizer (Hospira) Biotechnological Drugs Basic Information
9.13.2 Pfizer (Hospira) Biotechnological Drugs Product Overview
9.13.3 Pfizer (Hospira) Biotechnological Drugs Product Market Performance
9.13.4 Pfizer (Hospira) Business Overview
9.13.5 Pfizer (Hospira) Recent Developments
9.14 Shanghai Lansheng Guojian Pharmaceutical
9.14.1 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Basic Information
9.14.2 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Overview
9.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Market Performance
9.14.4 Shanghai Lansheng Guojian Pharmaceutical Business Overview
9.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
9.15 Shenzhen Neptunus Interlong Bio-Technique
9.15.1 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Basic Information
9.15.2 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Overview
9.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Market Performance
9.15.4 Shenzhen Neptunus Interlong Bio-Technique Business Overview
9.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
9.16 Tonghua Dongbao Pharmaceutical
9.16.1 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Basic Information
9.16.2 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Overview
9.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Market Performance
9.16.4 Tonghua Dongbao Pharmaceutical Business Overview
9.16.5 Tonghua Dongbao Pharmaceutical Recent Developments
9.17 Torrent Pharmaceuticals
9.17.1 Torrent Pharmaceuticals Biotechnological Drugs Basic Information
9.17.2 Torrent Pharmaceuticals Biotechnological Drugs Product Overview
9.17.3 Torrent Pharmaceuticals Biotechnological Drugs Product Market Performance
9.17.4 Torrent Pharmaceuticals Business Overview
9.17.5 Torrent Pharmaceuticals Recent Developments
10 BIOTECHNOLOGICAL DRUGS MARKET FORECAST BY REGION
10.1 Global Biotechnological Drugs Market Size Forecast
10.2 Global Biotechnological Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biotechnological Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Biotechnological Drugs Market Size Forecast by Region
10.2.4 South America Biotechnological Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biotechnological Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Biotechnological Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Biotechnological Drugs by Type (2024-2029)
11.1.2 Global Biotechnological Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Biotechnological Drugs by Type (2024-2029)
11.2 Global Biotechnological Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Biotechnological Drugs Sales (K Units) Forecast by Application
11.2.2 Global Biotechnological Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biotechnological Drugs
1.2 Key Market Segments
1.2.1 Biotechnological Drugs Segment by Type
1.2.2 Biotechnological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOTECHNOLOGICAL DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biotechnological Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Biotechnological Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOTECHNOLOGICAL DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Biotechnological Drugs Sales by Manufacturers (2018-2023)
3.2 Global Biotechnological Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biotechnological Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Biotechnological Drugs Sales Sites, Area Served, Product Type
3.6 Biotechnological Drugs Market Competitive Situation and Trends
3.6.1 Biotechnological Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biotechnological Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOTECHNOLOGICAL DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Biotechnological Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOTECHNOLOGICAL DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biotechnological Drugs Sales Market Share by Type (2018-2023)
6.3 Global Biotechnological Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Biotechnological Drugs Price by Type (2018-2023)
7 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biotechnological Drugs Market Sales by Application (2018-2023)
7.3 Global Biotechnological Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Biotechnological Drugs Sales Growth Rate by Application (2018-2023)
8 BIOTECHNOLOGICAL DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Biotechnological Drugs Sales by Region
8.1.1 Global Biotechnological Drugs Sales by Region
8.1.2 Global Biotechnological Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Biotechnological Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biotechnological Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biotechnological Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biotechnological Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biotechnological Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 3SBIO
9.1.1 3SBIO Biotechnological Drugs Basic Information
9.1.2 3SBIO Biotechnological Drugs Product Overview
9.1.3 3SBIO Biotechnological Drugs Product Market Performance
9.1.4 3SBIO Business Overview
9.1.5 3SBIO Biotechnological Drugs SWOT Analysis
9.1.6 3SBIO Recent Developments
9.2 Anhui Anke Biotechnology
9.2.1 Anhui Anke Biotechnology Biotechnological Drugs Basic Information
9.2.2 Anhui Anke Biotechnology Biotechnological Drugs Product Overview
9.2.3 Anhui Anke Biotechnology Biotechnological Drugs Product Market Performance
9.2.4 Anhui Anke Biotechnology Business Overview
9.2.5 Anhui Anke Biotechnology Biotechnological Drugs SWOT Analysis
9.2.6 Anhui Anke Biotechnology Recent Developments
9.3 Beijing SL Pharmaceutical
9.3.1 Beijing SL Pharmaceutical Biotechnological Drugs Basic Information
9.3.2 Beijing SL Pharmaceutical Biotechnological Drugs Product Overview
9.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Product Market Performance
9.3.4 Beijing SL Pharmaceutical Business Overview
9.3.5 Beijing SL Pharmaceutical Biotechnological Drugs SWOT Analysis
9.3.6 Beijing SL Pharmaceutical Recent Developments
9.4 Biotech Pharmaceutical
9.4.1 Biotech Pharmaceutical Biotechnological Drugs Basic Information
9.4.2 Biotech Pharmaceutical Biotechnological Drugs Product Overview
9.4.3 Biotech Pharmaceutical Biotechnological Drugs Product Market Performance
9.4.4 Biotech Pharmaceutical Business Overview
9.4.5 Biotech Pharmaceutical Biotechnological Drugs SWOT Analysis
9.4.6 Biotech Pharmaceutical Recent Developments
9.5 Cadila Healthcare
9.5.1 Cadila Healthcare Biotechnological Drugs Basic Information
9.5.2 Cadila Healthcare Biotechnological Drugs Product Overview
9.5.3 Cadila Healthcare Biotechnological Drugs Product Market Performance
9.5.4 Cadila Healthcare Business Overview
9.5.5 Cadila Healthcare Biotechnological Drugs SWOT Analysis
9.5.6 Cadila Healthcare Recent Developments
9.6 Celgen Biopharma
9.6.1 Celgen Biopharma Biotechnological Drugs Basic Information
9.6.2 Celgen Biopharma Biotechnological Drugs Product Overview
9.6.3 Celgen Biopharma Biotechnological Drugs Product Market Performance
9.6.4 Celgen Biopharma Business Overview
9.6.5 Celgen Biopharma Recent Developments
9.7 Celltrion
9.7.1 Celltrion Biotechnological Drugs Basic Information
9.7.2 Celltrion Biotechnological Drugs Product Overview
9.7.3 Celltrion Biotechnological Drugs Product Market Performance
9.7.4 Celltrion Business Overview
9.7.5 Celltrion Recent Developments
9.8 Dr Reddy’s
9.8.1 Dr Reddy’s Biotechnological Drugs Basic Information
9.8.2 Dr Reddy’s Biotechnological Drugs Product Overview
9.8.3 Dr Reddy’s Biotechnological Drugs Product Market Performance
9.8.4 Dr Reddy’s Business Overview
9.8.5 Dr Reddy’s Recent Developments
9.9 GeneScience Pharmaceuticals
9.9.1 GeneScience Pharmaceuticals Biotechnological Drugs Basic Information
9.9.2 GeneScience Pharmaceuticals Biotechnological Drugs Product Overview
9.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Product Market Performance
9.9.4 GeneScience Pharmaceuticals Business Overview
9.9.5 GeneScience Pharmaceuticals Recent Developments
9.10 Hisun Pharma
9.10.1 Hisun Pharma Biotechnological Drugs Basic Information
9.10.2 Hisun Pharma Biotechnological Drugs Product Overview
9.10.3 Hisun Pharma Biotechnological Drugs Product Market Performance
9.10.4 Hisun Pharma Business Overview
9.10.5 Hisun Pharma Recent Developments
9.11 Jiangsu Sihuan Bioengineering
9.11.1 Jiangsu Sihuan Bioengineering Biotechnological Drugs Basic Information
9.11.2 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Overview
9.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Market Performance
9.11.4 Jiangsu Sihuan Bioengineering Business Overview
9.11.5 Jiangsu Sihuan Bioengineering Recent Developments
9.12 Novartis (Sandoz)
9.12.1 Novartis (Sandoz) Biotechnological Drugs Basic Information
9.12.2 Novartis (Sandoz) Biotechnological Drugs Product Overview
9.12.3 Novartis (Sandoz) Biotechnological Drugs Product Market Performance
9.12.4 Novartis (Sandoz) Business Overview
9.12.5 Novartis (Sandoz) Recent Developments
9.13 Pfizer (Hospira)
9.13.1 Pfizer (Hospira) Biotechnological Drugs Basic Information
9.13.2 Pfizer (Hospira) Biotechnological Drugs Product Overview
9.13.3 Pfizer (Hospira) Biotechnological Drugs Product Market Performance
9.13.4 Pfizer (Hospira) Business Overview
9.13.5 Pfizer (Hospira) Recent Developments
9.14 Shanghai Lansheng Guojian Pharmaceutical
9.14.1 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Basic Information
9.14.2 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Overview
9.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Market Performance
9.14.4 Shanghai Lansheng Guojian Pharmaceutical Business Overview
9.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
9.15 Shenzhen Neptunus Interlong Bio-Technique
9.15.1 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Basic Information
9.15.2 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Overview
9.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Market Performance
9.15.4 Shenzhen Neptunus Interlong Bio-Technique Business Overview
9.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
9.16 Tonghua Dongbao Pharmaceutical
9.16.1 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Basic Information
9.16.2 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Overview
9.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Market Performance
9.16.4 Tonghua Dongbao Pharmaceutical Business Overview
9.16.5 Tonghua Dongbao Pharmaceutical Recent Developments
9.17 Torrent Pharmaceuticals
9.17.1 Torrent Pharmaceuticals Biotechnological Drugs Basic Information
9.17.2 Torrent Pharmaceuticals Biotechnological Drugs Product Overview
9.17.3 Torrent Pharmaceuticals Biotechnological Drugs Product Market Performance
9.17.4 Torrent Pharmaceuticals Business Overview
9.17.5 Torrent Pharmaceuticals Recent Developments
10 BIOTECHNOLOGICAL DRUGS MARKET FORECAST BY REGION
10.1 Global Biotechnological Drugs Market Size Forecast
10.2 Global Biotechnological Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biotechnological Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Biotechnological Drugs Market Size Forecast by Region
10.2.4 South America Biotechnological Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biotechnological Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Biotechnological Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Biotechnological Drugs by Type (2024-2029)
11.1.2 Global Biotechnological Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Biotechnological Drugs by Type (2024-2029)
11.2 Global Biotechnological Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Biotechnological Drugs Sales (K Units) Forecast by Application
11.2.2 Global Biotechnological Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biotechnological Drugs Market Size Comparison by Region (M USD)
Table 5. Global Biotechnological Drugs Sales (K Units) by Manufacturers (2018-2023)
Table 6. Global Biotechnological Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Biotechnological Drugs Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Biotechnological Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2022)
Table 10. Global Market Biotechnological Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Biotechnological Drugs Sales Sites and Area Served
Table 12. Manufacturers Biotechnological Drugs Product Type
Table 13. Global Biotechnological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biotechnological Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biotechnological Drugs Market Challenges
Table 22. Market Restraints
Table 23. Global Biotechnological Drugs Sales by Type (K Units)
Table 24. Global Biotechnological Drugs Market Size by Type (M USD)
Table 25. Global Biotechnological Drugs Sales (K Units) by Type (2018-2023)
Table 26. Global Biotechnological Drugs Sales Market Share by Type (2018-2023)
Table 27. Global Biotechnological Drugs Market Size (M USD) by Type (2018-2023)
Table 28. Global Biotechnological Drugs Market Size Share by Type (2018-2023)
Table 29. Global Biotechnological Drugs Price (USD/Unit) by Type (2018-2023)
Table 30. Global Biotechnological Drugs Sales (K Units) by Application
Table 31. Global Biotechnological Drugs Market Size by Application
Table 32. Global Biotechnological Drugs Sales by Application (2018-2023) & (K Units)
Table 33. Global Biotechnological Drugs Sales Market Share by Application (2018-2023)
Table 34. Global Biotechnological Drugs Sales by Application (2018-2023) & (M USD)
Table 35. Global Biotechnological Drugs Market Share by Application (2018-2023)
Table 36. Global Biotechnological Drugs Sales Growth Rate by Application (2018-2023)
Table 37. Global Biotechnological Drugs Sales by Region (2018-2023) & (K Units)
Table 38. Global Biotechnological Drugs Sales Market Share by Region (2018-2023)
Table 39. North America Biotechnological Drugs Sales by Country (2018-2023) & (K Units)
Table 40. Europe Biotechnological Drugs Sales by Country (2018-2023) & (K Units)
Table 41. Asia Pacific Biotechnological Drugs Sales by Region (2018-2023) & (K Units)
Table 42. South America Biotechnological Drugs Sales by Country (2018-2023) & (K Units)
Table 43. Middle East and Africa Biotechnological Drugs Sales by Region (2018-2023) & (K Units)
Table 44. 3SBIO Biotechnological Drugs Basic Information
Table 45. 3SBIO Biotechnological Drugs Product Overview
Table 46. 3SBIO Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 47. 3SBIO Business Overview
Table 48. 3SBIO Biotechnological Drugs SWOT Analysis
Table 49. 3SBIO Recent Developments
Table 50. Anhui Anke Biotechnology Biotechnological Drugs Basic Information
Table 51. Anhui Anke Biotechnology Biotechnological Drugs Product Overview
Table 52. Anhui Anke Biotechnology Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 53. Anhui Anke Biotechnology Business Overview
Table 54. Anhui Anke Biotechnology Biotechnological Drugs SWOT Analysis
Table 55. Anhui Anke Biotechnology Recent Developments
Table 56. Beijing SL Pharmaceutical Biotechnological Drugs Basic Information
Table 57. Beijing SL Pharmaceutical Biotechnological Drugs Product Overview
Table 58. Beijing SL Pharmaceutical Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Beijing SL Pharmaceutical Business Overview
Table 60. Beijing SL Pharmaceutical Biotechnological Drugs SWOT Analysis
Table 61. Beijing SL Pharmaceutical Recent Developments
Table 62. Biotech Pharmaceutical Biotechnological Drugs Basic Information
Table 63. Biotech Pharmaceutical Biotechnological Drugs Product Overview
Table 64. Biotech Pharmaceutical Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. Biotech Pharmaceutical Business Overview
Table 66. Biotech Pharmaceutical Biotechnological Drugs SWOT Analysis
Table 67. Biotech Pharmaceutical Recent Developments
Table 68. Cadila Healthcare Biotechnological Drugs Basic Information
Table 69. Cadila Healthcare Biotechnological Drugs Product Overview
Table 70. Cadila Healthcare Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 71. Cadila Healthcare Business Overview
Table 72. Cadila Healthcare Biotechnological Drugs SWOT Analysis
Table 73. Cadila Healthcare Recent Developments
Table 74. Celgen Biopharma Biotechnological Drugs Basic Information
Table 75. Celgen Biopharma Biotechnological Drugs Product Overview
Table 76. Celgen Biopharma Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Celgen Biopharma Business Overview
Table 78. Celgen Biopharma Recent Developments
Table 79. Celltrion Biotechnological Drugs Basic Information
Table 80. Celltrion Biotechnological Drugs Product Overview
Table 81. Celltrion Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Celltrion Business Overview
Table 83. Celltrion Recent Developments
Table 84. Dr Reddy’s Biotechnological Drugs Basic Information
Table 85. Dr Reddy’s Biotechnological Drugs Product Overview
Table 86. Dr Reddy’s Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Dr Reddy’s Business Overview
Table 88. Dr Reddy’s Recent Developments
Table 89. GeneScience Pharmaceuticals Biotechnological Drugs Basic Information
Table 90. GeneScience Pharmaceuticals Biotechnological Drugs Product Overview
Table 91. GeneScience Pharmaceuticals Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. GeneScience Pharmaceuticals Business Overview
Table 93. GeneScience Pharmaceuticals Recent Developments
Table 94. Hisun Pharma Biotechnological Drugs Basic Information
Table 95. Hisun Pharma Biotechnological Drugs Product Overview
Table 96. Hisun Pharma Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Hisun Pharma Business Overview
Table 98. Hisun Pharma Recent Developments
Table 99. Jiangsu Sihuan Bioengineering Biotechnological Drugs Basic Information
Table 100. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Overview
Table 101. Jiangsu Sihuan Bioengineering Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Jiangsu Sihuan Bioengineering Business Overview
Table 103. Jiangsu Sihuan Bioengineering Recent Developments
Table 104. Novartis (Sandoz) Biotechnological Drugs Basic Information
Table 105. Novartis (Sandoz) Biotechnological Drugs Product Overview
Table 106. Novartis (Sandoz) Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Novartis (Sandoz) Business Overview
Table 108. Novartis (Sandoz) Recent Developments
Table 109. Pfizer (Hospira) Biotechnological Drugs Basic Information
Table 110. Pfizer (Hospira) Biotechnological Drugs Product Overview
Table 111. Pfizer (Hospira) Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Pfizer (Hospira) Business Overview
Table 113. Pfizer (Hospira) Recent Developments
Table 114. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Basic Information
Table 115. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Overview
Table 116. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Shanghai Lansheng Guojian Pharmaceutical Business Overview
Table 118. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 119. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Basic Information
Table 120. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Overview
Table 121. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Shenzhen Neptunus Interlong Bio-Technique Business Overview
Table 123. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 124. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Basic Information
Table 125. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Overview
Table 126. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Tonghua Dongbao Pharmaceutical Business Overview
Table 128. Tonghua Dongbao Pharmaceutical Recent Developments
Table 129. Torrent Pharmaceuticals Biotechnological Drugs Basic Information
Table 130. Torrent Pharmaceuticals Biotechnological Drugs Product Overview
Table 131. Torrent Pharmaceuticals Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Torrent Pharmaceuticals Business Overview
Table 133. Torrent Pharmaceuticals Recent Developments
Table 134. Global Biotechnological Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 135. Global Biotechnological Drugs Market Size Forecast by Region (2024-2029) & (M USD)
Table 136. North America Biotechnological Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 137. North America Biotechnological Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 138. Europe Biotechnological Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 139. Europe Biotechnological Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 140. Asia Pacific Biotechnological Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 141. Asia Pacific Biotechnological Drugs Market Size Forecast by Region (2024-2029) & (M USD)
Table 142. South America Biotechnological Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 143. South America Biotechnological Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 144. Middle East and Africa Biotechnological Drugs Consumption Forecast by Country (2024-2029) & (Units)
Table 145. Middle East and Africa Biotechnological Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 146. Global Biotechnological Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 147. Global Biotechnological Drugs Market Size Forecast by Type (2024-2029) & (M USD)
Table 148. Global Biotechnological Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 149. Global Biotechnological Drugs Sales (K Units) Forecast by Application (2024-2029)
Table 150. Global Biotechnological Drugs Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biotechnological Drugs Market Size Comparison by Region (M USD)
Table 5. Global Biotechnological Drugs Sales (K Units) by Manufacturers (2018-2023)
Table 6. Global Biotechnological Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Biotechnological Drugs Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Biotechnological Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnological Drugs as of 2022)
Table 10. Global Market Biotechnological Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Biotechnological Drugs Sales Sites and Area Served
Table 12. Manufacturers Biotechnological Drugs Product Type
Table 13. Global Biotechnological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biotechnological Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biotechnological Drugs Market Challenges
Table 22. Market Restraints
Table 23. Global Biotechnological Drugs Sales by Type (K Units)
Table 24. Global Biotechnological Drugs Market Size by Type (M USD)
Table 25. Global Biotechnological Drugs Sales (K Units) by Type (2018-2023)
Table 26. Global Biotechnological Drugs Sales Market Share by Type (2018-2023)
Table 27. Global Biotechnological Drugs Market Size (M USD) by Type (2018-2023)
Table 28. Global Biotechnological Drugs Market Size Share by Type (2018-2023)
Table 29. Global Biotechnological Drugs Price (USD/Unit) by Type (2018-2023)
Table 30. Global Biotechnological Drugs Sales (K Units) by Application
Table 31. Global Biotechnological Drugs Market Size by Application
Table 32. Global Biotechnological Drugs Sales by Application (2018-2023) & (K Units)
Table 33. Global Biotechnological Drugs Sales Market Share by Application (2018-2023)
Table 34. Global Biotechnological Drugs Sales by Application (2018-2023) & (M USD)
Table 35. Global Biotechnological Drugs Market Share by Application (2018-2023)
Table 36. Global Biotechnological Drugs Sales Growth Rate by Application (2018-2023)
Table 37. Global Biotechnological Drugs Sales by Region (2018-2023) & (K Units)
Table 38. Global Biotechnological Drugs Sales Market Share by Region (2018-2023)
Table 39. North America Biotechnological Drugs Sales by Country (2018-2023) & (K Units)
Table 40. Europe Biotechnological Drugs Sales by Country (2018-2023) & (K Units)
Table 41. Asia Pacific Biotechnological Drugs Sales by Region (2018-2023) & (K Units)
Table 42. South America Biotechnological Drugs Sales by Country (2018-2023) & (K Units)
Table 43. Middle East and Africa Biotechnological Drugs Sales by Region (2018-2023) & (K Units)
Table 44. 3SBIO Biotechnological Drugs Basic Information
Table 45. 3SBIO Biotechnological Drugs Product Overview
Table 46. 3SBIO Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 47. 3SBIO Business Overview
Table 48. 3SBIO Biotechnological Drugs SWOT Analysis
Table 49. 3SBIO Recent Developments
Table 50. Anhui Anke Biotechnology Biotechnological Drugs Basic Information
Table 51. Anhui Anke Biotechnology Biotechnological Drugs Product Overview
Table 52. Anhui Anke Biotechnology Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 53. Anhui Anke Biotechnology Business Overview
Table 54. Anhui Anke Biotechnology Biotechnological Drugs SWOT Analysis
Table 55. Anhui Anke Biotechnology Recent Developments
Table 56. Beijing SL Pharmaceutical Biotechnological Drugs Basic Information
Table 57. Beijing SL Pharmaceutical Biotechnological Drugs Product Overview
Table 58. Beijing SL Pharmaceutical Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Beijing SL Pharmaceutical Business Overview
Table 60. Beijing SL Pharmaceutical Biotechnological Drugs SWOT Analysis
Table 61. Beijing SL Pharmaceutical Recent Developments
Table 62. Biotech Pharmaceutical Biotechnological Drugs Basic Information
Table 63. Biotech Pharmaceutical Biotechnological Drugs Product Overview
Table 64. Biotech Pharmaceutical Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. Biotech Pharmaceutical Business Overview
Table 66. Biotech Pharmaceutical Biotechnological Drugs SWOT Analysis
Table 67. Biotech Pharmaceutical Recent Developments
Table 68. Cadila Healthcare Biotechnological Drugs Basic Information
Table 69. Cadila Healthcare Biotechnological Drugs Product Overview
Table 70. Cadila Healthcare Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 71. Cadila Healthcare Business Overview
Table 72. Cadila Healthcare Biotechnological Drugs SWOT Analysis
Table 73. Cadila Healthcare Recent Developments
Table 74. Celgen Biopharma Biotechnological Drugs Basic Information
Table 75. Celgen Biopharma Biotechnological Drugs Product Overview
Table 76. Celgen Biopharma Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Celgen Biopharma Business Overview
Table 78. Celgen Biopharma Recent Developments
Table 79. Celltrion Biotechnological Drugs Basic Information
Table 80. Celltrion Biotechnological Drugs Product Overview
Table 81. Celltrion Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Celltrion Business Overview
Table 83. Celltrion Recent Developments
Table 84. Dr Reddy’s Biotechnological Drugs Basic Information
Table 85. Dr Reddy’s Biotechnological Drugs Product Overview
Table 86. Dr Reddy’s Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Dr Reddy’s Business Overview
Table 88. Dr Reddy’s Recent Developments
Table 89. GeneScience Pharmaceuticals Biotechnological Drugs Basic Information
Table 90. GeneScience Pharmaceuticals Biotechnological Drugs Product Overview
Table 91. GeneScience Pharmaceuticals Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. GeneScience Pharmaceuticals Business Overview
Table 93. GeneScience Pharmaceuticals Recent Developments
Table 94. Hisun Pharma Biotechnological Drugs Basic Information
Table 95. Hisun Pharma Biotechnological Drugs Product Overview
Table 96. Hisun Pharma Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Hisun Pharma Business Overview
Table 98. Hisun Pharma Recent Developments
Table 99. Jiangsu Sihuan Bioengineering Biotechnological Drugs Basic Information
Table 100. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product Overview
Table 101. Jiangsu Sihuan Bioengineering Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Jiangsu Sihuan Bioengineering Business Overview
Table 103. Jiangsu Sihuan Bioengineering Recent Developments
Table 104. Novartis (Sandoz) Biotechnological Drugs Basic Information
Table 105. Novartis (Sandoz) Biotechnological Drugs Product Overview
Table 106. Novartis (Sandoz) Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Novartis (Sandoz) Business Overview
Table 108. Novartis (Sandoz) Recent Developments
Table 109. Pfizer (Hospira) Biotechnological Drugs Basic Information
Table 110. Pfizer (Hospira) Biotechnological Drugs Product Overview
Table 111. Pfizer (Hospira) Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Pfizer (Hospira) Business Overview
Table 113. Pfizer (Hospira) Recent Developments
Table 114. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Basic Information
Table 115. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product Overview
Table 116. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Shanghai Lansheng Guojian Pharmaceutical Business Overview
Table 118. Shanghai Lansheng Guojian Pharmaceutical Recent Developments
Table 119. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Basic Information
Table 120. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product Overview
Table 121. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Shenzhen Neptunus Interlong Bio-Technique Business Overview
Table 123. Shenzhen Neptunus Interlong Bio-Technique Recent Developments
Table 124. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Basic Information
Table 125. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product Overview
Table 126. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Tonghua Dongbao Pharmaceutical Business Overview
Table 128. Tonghua Dongbao Pharmaceutical Recent Developments
Table 129. Torrent Pharmaceuticals Biotechnological Drugs Basic Information
Table 130. Torrent Pharmaceuticals Biotechnological Drugs Product Overview
Table 131. Torrent Pharmaceuticals Biotechnological Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Torrent Pharmaceuticals Business Overview
Table 133. Torrent Pharmaceuticals Recent Developments
Table 134. Global Biotechnological Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 135. Global Biotechnological Drugs Market Size Forecast by Region (2024-2029) & (M USD)
Table 136. North America Biotechnological Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 137. North America Biotechnological Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 138. Europe Biotechnological Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 139. Europe Biotechnological Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 140. Asia Pacific Biotechnological Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 141. Asia Pacific Biotechnological Drugs Market Size Forecast by Region (2024-2029) & (M USD)
Table 142. South America Biotechnological Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 143. South America Biotechnological Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 144. Middle East and Africa Biotechnological Drugs Consumption Forecast by Country (2024-2029) & (Units)
Table 145. Middle East and Africa Biotechnological Drugs Market Size Forecast by Country (2024-2029) & (M USD)
Table 146. Global Biotechnological Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 147. Global Biotechnological Drugs Market Size Forecast by Type (2024-2029) & (M USD)
Table 148. Global Biotechnological Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 149. Global Biotechnological Drugs Sales (K Units) Forecast by Application (2024-2029)
Table 150. Global Biotechnological Drugs Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biotechnological Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biotechnological Drugs Market Size (M USD), 2018-2029
Figure 5. Global Biotechnological Drugs Market Size (M USD) (2018-2029)
Figure 6. Global Biotechnological Drugs Sales (K Units) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biotechnological Drugs Market Size by Country (M USD)
Figure 11. Biotechnological Drugs Sales Share by Manufacturers in 2022
Figure 12. Global Biotechnological Drugs Revenue Share by Manufacturers in 2022
Figure 13. Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Biotechnological Drugs Average Price (USD/Unit) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biotechnological Drugs Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biotechnological Drugs Market Share by Type
Figure 18. Sales Market Share of Biotechnological Drugs by Type (2018-2023)
Figure 19. Sales Market Share of Biotechnological Drugs by Type in 2022
Figure 20. Market Size Share of Biotechnological Drugs by Type (2018-2023)
Figure 21. Market Size Market Share of Biotechnological Drugs by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biotechnological Drugs Market Share by Application
Figure 24. Global Biotechnological Drugs Sales Market Share by Application (2018-2023)
Figure 25. Global Biotechnological Drugs Sales Market Share by Application in 2022
Figure 26. Global Biotechnological Drugs Market Share by Application (2018-2023)
Figure 27. Global Biotechnological Drugs Market Share by Application in 2022
Figure 28. Global Biotechnological Drugs Sales Growth Rate by Application (2018-2023)
Figure 29. Global Biotechnological Drugs Sales Market Share by Region (2018-2023)
Figure 30. North America Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 31. North America Biotechnological Drugs Sales Market Share by Country in 2022
Figure 32. U.S. Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 33. Canada Biotechnological Drugs Sales (K Units) and Growth Rate (2018-2023)
Figure 34. Mexico Biotechnological Drugs Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 36. Europe Biotechnological Drugs Sales Market Share by Country in 2022
Figure 37. Germany Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 38. France Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 39. U.K. Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 40. Italy Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 41. Russia Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 42. Asia Pacific Biotechnological Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biotechnological Drugs Sales Market Share by Region in 2022
Figure 44. China Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 45. Japan Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 46. South Korea Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 47. India Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 48. Southeast Asia Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 49. South America Biotechnological Drugs Sales and Growth Rate (K Units)
Figure 50. South America Biotechnological Drugs Sales Market Share by Country in 2022
Figure 51. Brazil Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 52. Argentina Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 53. Columbia Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 54. Middle East and Africa Biotechnological Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biotechnological Drugs Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 57. UAE Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 58. Egypt Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 59. Nigeria Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 60. South Africa Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 61. Global Biotechnological Drugs Sales Forecast by Volume (2018-2029) & (K Units)
Figure 62. Global Biotechnological Drugs Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Biotechnological Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Biotechnological Drugs Market Share Forecast by Type (2024-2029)
Figure 65. Global Biotechnological Drugs Sales Forecast by Application (2024-2029)
Figure 66. Global Biotechnological Drugs Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of Biotechnological Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biotechnological Drugs Market Size (M USD), 2018-2029
Figure 5. Global Biotechnological Drugs Market Size (M USD) (2018-2029)
Figure 6. Global Biotechnological Drugs Sales (K Units) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biotechnological Drugs Market Size by Country (M USD)
Figure 11. Biotechnological Drugs Sales Share by Manufacturers in 2022
Figure 12. Global Biotechnological Drugs Revenue Share by Manufacturers in 2022
Figure 13. Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Biotechnological Drugs Average Price (USD/Unit) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biotechnological Drugs Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biotechnological Drugs Market Share by Type
Figure 18. Sales Market Share of Biotechnological Drugs by Type (2018-2023)
Figure 19. Sales Market Share of Biotechnological Drugs by Type in 2022
Figure 20. Market Size Share of Biotechnological Drugs by Type (2018-2023)
Figure 21. Market Size Market Share of Biotechnological Drugs by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biotechnological Drugs Market Share by Application
Figure 24. Global Biotechnological Drugs Sales Market Share by Application (2018-2023)
Figure 25. Global Biotechnological Drugs Sales Market Share by Application in 2022
Figure 26. Global Biotechnological Drugs Market Share by Application (2018-2023)
Figure 27. Global Biotechnological Drugs Market Share by Application in 2022
Figure 28. Global Biotechnological Drugs Sales Growth Rate by Application (2018-2023)
Figure 29. Global Biotechnological Drugs Sales Market Share by Region (2018-2023)
Figure 30. North America Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 31. North America Biotechnological Drugs Sales Market Share by Country in 2022
Figure 32. U.S. Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 33. Canada Biotechnological Drugs Sales (K Units) and Growth Rate (2018-2023)
Figure 34. Mexico Biotechnological Drugs Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 36. Europe Biotechnological Drugs Sales Market Share by Country in 2022
Figure 37. Germany Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 38. France Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 39. U.K. Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 40. Italy Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 41. Russia Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 42. Asia Pacific Biotechnological Drugs Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biotechnological Drugs Sales Market Share by Region in 2022
Figure 44. China Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 45. Japan Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 46. South Korea Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 47. India Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 48. Southeast Asia Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 49. South America Biotechnological Drugs Sales and Growth Rate (K Units)
Figure 50. South America Biotechnological Drugs Sales Market Share by Country in 2022
Figure 51. Brazil Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 52. Argentina Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 53. Columbia Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 54. Middle East and Africa Biotechnological Drugs Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biotechnological Drugs Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 57. UAE Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 58. Egypt Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 59. Nigeria Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 60. South Africa Biotechnological Drugs Sales and Growth Rate (2018-2023) & (K Units)
Figure 61. Global Biotechnological Drugs Sales Forecast by Volume (2018-2029) & (K Units)
Figure 62. Global Biotechnological Drugs Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Biotechnological Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Biotechnological Drugs Market Share Forecast by Type (2024-2029)
Figure 65. Global Biotechnological Drugs Sales Forecast by Application (2024-2029)
Figure 66. Global Biotechnological Drugs Market Share Forecast by Application (2024-2029)
